Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial
about
Effect of Pharmacological Interventions on the Fronto-Cingulo-Parietal Cognitive Control Network in Psychiatric Disorders: A Transdiagnostic Systematic Review of fMRI StudiesSmoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis.Alpha-7 nicotinic agonists for cognitive deficits in neuropsychiatric disorders: A translational meta-analysis of rodent and human studies.Evaluating an Adaptive and Interactive mHealth Smoking Cessation and Medication Adherence Program: A Randomized Pilot Feasibility Study.Improved Depressive Symptoms in Adults with Schizophrenia During a Smoking Cessation Attempt with Varenicline and Behavioral Therapy.Alpha7 nAChR Agonists for Cognitive Deficit and Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Double-blind Controlled TrialsPharmacological Augmentation of Psychosocial and Remediation Training Efforts in Schizophrenia.Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia.The effects of nicotine in the neonatal quinpirole rodent model of psychosis: Neural plasticity mechanisms and nicotinic receptor changes.Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorder.Association between lower estimated premorbid intelligence quotient and smoking behavior in patients with schizophrenia
P2860
Q26744718-88517B0E-7411-4C73-92D2-3D07E771C00EQ33909736-12F4C1B1-6B76-4DEB-842E-745F0977B33FQ36243977-A841C383-8616-44B9-88B7-7E713848A7CDQ37184722-7994F58A-E235-4CF2-B51C-E19594101A89Q38834502-68F080E6-EEA9-4CBC-B85E-CD8871ED0C8BQ41687338-6CF1DEFB-A2D3-4A5B-A043-35BBBDF37083Q42367850-613C19E4-3B77-4CD5-A22C-287DAD6E3C60Q47753299-83F6999D-F28E-402C-BCC6-2166E7090AB9Q47848449-F0745B18-67B2-4244-8FDE-986C2A8ECE09Q51015889-B665F758-E230-49C9-A565-AB835967015EQ57480975-51256F88-360E-4D57-9171-9CD3A35D0C5E
P2860
Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Varenicline Effects on Smoking ...... Double-Blind Randomized Trial
@ast
Varenicline Effects on Smoking ...... Double-Blind Randomized Trial
@en
Varenicline Effects on Smoking ...... Double-Blind Randomized Trial
@nl
type
label
Varenicline Effects on Smoking ...... Double-Blind Randomized Trial
@ast
Varenicline Effects on Smoking ...... Double-Blind Randomized Trial
@en
Varenicline Effects on Smoking ...... Double-Blind Randomized Trial
@nl
prefLabel
Varenicline Effects on Smoking ...... Double-Blind Randomized Trial
@ast
Varenicline Effects on Smoking ...... Double-Blind Randomized Trial
@en
Varenicline Effects on Smoking ...... Double-Blind Randomized Trial
@nl
P2093
P2860
P3181
P1433
P1476
Varenicline Effects on Smoking ...... Double-Blind Randomized Trial
@en
P2093
Abel Lajtha
Alessandro Guidotti
Henry Sershen
John M Davis
Juanjuan Ren
Lawrence Maayan
Mark Weiser
Mary Youseff
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0143490
P407
P577
2016-01-01T00:00:00Z